Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Pulmonary Hypertension, April 2021

Free Subscription


Abstracts

Retrieve all available abstracts of the following 166 articles:
HTML format


 

Single Articles

  1. SONG JL, Zheng SY, He RL, Gui LX, et al
    Serotonin and chronic hypoxic pulmonary hypertension activate a NADPH oxidase 4 and TRPM2 dependent pathway for pulmonary arterial smooth muscle cell proliferation and migration.
    Vascul Pharmacol. 2021 Mar 29:106860. doi: 10.1016/j.vph.2021.106860.
    PubMed    
    Abstract available

  2. MANDURINO-MIRIZZI A, Tua L, Arzuffi L, Demarchi A, et al
    Transcatheter mitral valve repair with MitraClip in patients with pulmonary hypertension: hemodynamic and prognostic perspectives.
    Rev Cardiovasc Med. 2021;22:33-38.
    PubMed    
    Abstract available

  3. THOMAS L, Baczynski M, Deshpande P, Kharrat A, et al
    Multicentre prospective observational study exploring the predictive value of functional echocardiographic indices for early identification of preterm neonates at risk of developing chronic pulmonary hypertension secondary to chronic neonatal lung dis
    BMJ Open. 2021;11:e044924.
    PubMed    
    Abstract available

  4. RUDYK O, Aaronson PI
    Redox Regulation, Oxidative Stress, and Inflammation in Group 3 Pulmonary Hypertension.
    Adv Exp Med Biol. 2021;1303:209-241.
    PubMed    
    Abstract available

  5. GHOSH-CHOUDHARY S, Chan SY
    Evolving Schema for Employing Network Biology Approaches to Understand Pulmonary Hypertension.
    Adv Exp Med Biol. 2021;1303:57-69.
    PubMed    
    Abstract available

  6. ISHIKAWA T, Abe K, Takana-Ishikawa M, Yoshida K, et al
    Chronic Inhibition of Toll-Like Receptor 9 Ameliorates Pulmonary Hypertension in Rats.
    J Am Heart Assoc. 2021 Mar 31:e019247. doi: 10.1161/JAHA.120.019247.
    PubMed    
    Abstract available


  7. Corrigendum for The mechanism of ions in pulmonary hypertension.
    Pulm Circ. 2021;11:20458940211004444.
    PubMed    
    Abstract available

  8. ALBAK LJ, Shah AH, Tam JW
    Cardiac failure and pulmonary hypertension secondary to renal arteriovenous malformation: a case report.
    J Med Case Rep. 2021;15:177.
    PubMed    
    Abstract available

  9. MINAKAWA K, Yokokawa T, Ueda K, Nakajima O, et al
    Myeloproliferative neoplasm-driving Calr frameshift promotes the development of pulmonary hypertension in mice.
    J Hematol Oncol. 2021;14:52.
    PubMed    
    Abstract available

  10. LAFUENTE-ROMERO A, Rodriguez Ogando A
    Selexipag use for paediatric pulmonary hypertension: a single centre report focussed on congenital heart disease patients.
    Cardiol Young. 2021 Mar 30:1-3. doi: 10.1017/S1047951121000937.
    PubMed    
    Abstract available

  11. PEETERS LEJ, Cochius-den Otter SCM, Witjes BCM, Gischler SJ, et al
    An Accidental Repetitive 10-Fold Overdose of Sildenafil in a Young Infant with Pulmonary Hypertension.
    Neonatology. 2021 Mar 29:1-5. doi: 10.1159/000514380.
    PubMed    
    Abstract available

  12. RAFFAY TM, Bonilla-Fernandez K, Jafri A, Sopi RB, et al
    Bronchopulmonary Dysplasia and Pulmonary Hypertension: The Role of Smooth Muscle adh5.
    Am J Respir Cell Mol Biol. 2021 Mar 29. doi: 10.1165/rcmb.2020-0289.
    PubMed    
    Abstract available

  13. KAY FU
    Could Dual-Energy CT Become the "One-Stop Shop" Modality in Pulmonary Hypertension Workup?
    Radiol Cardiothorac Imaging. 2020;2:e200603.
    PubMed    


  14. BACON JL, Madden BP, Gissane C, Sayer C, et al
    Vascular and Parenchymal Enhancement Assessment by Dual-Phase Dual-Energy CT in the Diagnostic Investigation of Pulmonary Hypertension.
    Radiol Cardiothorac Imaging. 2020;2:e200009.
    PubMed    
    Abstract available

  15. FUETA PO, Eyituoyo HO, Igbinoba O, Roberts J, et al
    Cardiopulmonary Arrest and Pulmonary Hypertension in an Infant with Pertussis Case Report.
    Case Rep Infect Dis. 2021;2021:6686185.
    PubMed    
    Abstract available

  16. JIAO JC, Li L, Tao SG, He XJ, et al
    [Ruptured chordae tendineae of tricuspid valve in neonate with intractable persistent pulmonary hypertension: a case report and literature review].
    Zhonghua Er Ke Za Zhi. 2021;59:294-298.
    PubMed    
    Abstract available

  17. HASSELBERG NE, Kagiyama N, Soyama Y, Sugahara M, et al
    The Prognostic Value of Right Atrial Strain Imaging in Patients with Pre-Capillary Pulmonary Hypertension.
    J Am Soc Echocardiogr. 2021 Mar 24. pii: S0894-7317(21)00141.
    PubMed    
    Abstract available

  18. EL-KHAZRAGY N, El Barbary M, Fouad H, Abdelgawad A, et al
    Association between genetic variations in carbamoyl-phosphate synthetase gene and persistent neonatal pulmonary hypertension.
    Eur J Pediatr. 2021 Mar 27. pii: 10.1007/s00431-021-04053.
    PubMed    
    Abstract available

  19. PLAUNT AJ, Islam S, Macaluso T, Gauani H, et al
    Development and Characterization of Treprostinil Palmitil Inhalation Aerosol for the Investigational Treatment of Pulmonary Arterial Hypertension.
    Int J Mol Sci. 2021;22.
    PubMed    
    Abstract available

  20. BRITTAIN EL, Niswender K, Agrawal V, Chen X, et al
    Mechanistic Phase II Clinical Trial of Metformin in Pulmonary Arterial Hypertension.
    J Am Heart Assoc. 2020;9:e018349.
    PubMed    
    Abstract available

  21. BENTLEY RF, Barker M, Esfandiari S, Wright SP, et al
    Normal and Abnormal Relationships of Pulmonary Artery to Wedge Pressure During Exercise.
    J Am Heart Assoc. 2020;9:e016339.
    PubMed    
    Abstract available

  22. MA Y, Chen SS, Feng YY, Wang HL, et al
    Identification of novel biomarkers involved in pulmonary arterial hypertension based on multiple-microarray analysis.
    Biosci Rep. 2020;40.
    PubMed    
    Abstract available

  23. DAY RW
    Acute vasodilator testing following Fontan palliation: an opportunity to guide precision care?
    Cardiol Young. 2020;30:829-833.
    PubMed    
    Abstract available

  24. ZHANG Y, Yuan RX, Bao D
    TGF-beta1 promotes pulmonary arterial hypertension in rats via activating RhoA/ROCK signaling pathway.
    Eur Rev Med Pharmacol Sci. 2020;24:4988-4996.
    PubMed    
    Abstract available

  25. PALLADINO-DAVIS AG, Davis CS
    Outcomes of infants and children undergoing surgical repair of ventricular septal defect: a review of the literature and implications for research with an emphasis on pulmonary artery hypertension.
    Cardiol Young. 2020;30:799-806.
    PubMed    
    Abstract available

  26. HAHN RT
    Finding concordance in discord: the value of discordant invasive and echocardiographic pulmonary artery pressure measurements with severe tricuspid regurgitation.
    Eur Heart J. 2020 Mar 16. pii: 5807654. doi: 10.1093.
    PubMed    


  27. KIM S, Rigatto K, Gazzana MB, Knorst MM, et al
    Altered Gut Microbiome Profile in Patients With Pulmonary Arterial Hypertension.
    Hypertension. 2020 Feb 24:HYPERTENSIONAHA11914294.
    PubMed    
    Abstract available

  28. MUGII N, Someya F
    Ability of the COPD Assessment Test to evaluate the lung-specific quality of life in systemic sclerosis-associated interstitial lung disease.
    Clin Respir J. 2020;14:527-532.
    PubMed    
    Abstract available

  29. IWATANI N, Kubota K, Ikeda Y, Tokushige A, et al
    Different characteristics of mitochondrial dynamics-related miRNAs on the hemodynamics of pulmonary artery hypertension and chronic thromboembolic pulmonary hypertension.
    J Cardiol. 2021 Apr 6. pii: S0914-5087(21)00071.
    PubMed    
    Abstract available

  30. ALNSASRA H, Case BC, Yang M, Rogers T, et al
    Pericardiocentesis induced right ventricular changes in patients with and without pulmonary hypertension.
    Echocardiography. 2021 Apr 9. doi: 10.1111/echo.15046.
    PubMed    
    Abstract available

  31. PORRES-AGUILAR M, Hoeper MM, Rivera-Lebron BN, Heresi GA, et al
    Direct oral anticoagulants in chronic thromboembolic pulmonary hypertension.
    J Thromb Thrombolysis. 2021 Apr 9. pii: 10.1007/s11239-021-02445.
    PubMed    
    Abstract available

  32. HANSMANN G, Christou H, Koestenberger M, Sallmon H, et al
    Off-label use of PAH-targeted medications approved for adults and their financial coverage by health insurances are vital for children with pulmonary hypertension.
    Eur J Clin Invest. 2021 Apr 9:e13571. doi: 10.1111/eci.13571.
    PubMed    
    Abstract available

  33. BAUCHMULLER K, Condliffe R, Southern J, Billings C, et al
    Critical care outcomes in patients with pre-existing pulmonary hypertension: insights from the ASPIRE registry.
    ERJ Open Res. 2021;7.
    PubMed    
    Abstract available

  34. YAN H, Zheng QY, Yang K, Chen YQ, et al
    [Research progress on the role and mechanism of hypoxia-inducible factor in the pathogenesis of pulmonary hypertension].
    Zhonghua Jie He He Hu Xi Za Zhi. 2021;44:396-399.
    PubMed    


  35. UELAND T, Abraityte A, Norum H, Varathalingam S, et al
    Circulating regulators of the wingless pathway in precapillary pulmonary hypertension.
    Respirology. 2021 Apr 8. doi: 10.1111/resp.14048.
    PubMed    
    Abstract available

  36. MANSOUR A, Roushdy A, Harb B, Attia H, et al
    Noninvasive Predictors of Functional Capacity in Patients with Pulmonary Hypertension due to Congenital Heart Disease: A Pilot Echocardiography Single-Center Study.
    J Cardiovasc Echogr. 2020;30:193-200.
    PubMed    
    Abstract available

  37. NUZZI V, Castrichini M, Collini V, Roman-Pognuz E, et al
    Impaired Right Ventricular Longitudinal Strain Without Pulmonary Hypertension in Patients Who Have Recovered From COVID-19.
    Circ Cardiovasc Imaging. 2021 Apr 8:CIRCIMAGING120012166.
    PubMed    


  38. CHRISTOU H, Michael Z, Spyropoulos F, Chen Y, et al
    Carbonic Anhydrase Inhibition Improves Pulmonary Artery Reactivity and Nitric Oxide-Mediated Relaxation in Sugen-Hypoxia Model of Pulmonary Hypertension.
    Am J Physiol Regul Integr Comp Physiol. 2021.
    PubMed    
    Abstract available

  39. WEST CM, Wearing OH, Rhem RG, Scott GR, et al
    Pulmonary hypertension is attenuated and ventilation-perfusion matching is maintained during chronic hypoxia in deer mice native to high altitude.
    Am J Physiol Regul Integr Comp Physiol. 2021.
    PubMed    
    Abstract available

  40. GRANOT Y, Rozenbaum Z, Ziv-Baran T, Berliner S, et al
    Detection of severe pulmonary hypertension based on computed tomography pulmonary angiography.
    Int J Cardiovasc Imaging. 2021 Apr 7. pii: 10.1007/s10554-021-02231.
    PubMed    
    Abstract available

  41. YAGHOOBI N, Mahdavi M, Maghsudi M, Malek H, et al
    Right ventricular ischemia by myocardial perfusion imaging in a 6-year-old child with pulmonary hypertension after ventricular septal defect repair.
    J Nucl Cardiol. 2021 Apr 6. pii: 10.1007/s12350-021-02590.
    PubMed    


  42. SATO S, Shimizu K, Ito T, Tsubono M, et al
    Increased Arterial Stiffness in Chronic Thromboembolic Pulmonary Hypertension Was Improved with Riociguat and Balloon Pulmonary Angioplasty: A Case Report.
    Int Med Case Rep J. 2021;14:191-197.
    PubMed    
    Abstract available

  43. GHIO S, Klersy C, Corsico A, Gamba SL, et al
    Risk stratification in patients with residual pulmonary hypertension after pulmonary endarterectomy.
    Int J Cardiol. 2021 Apr 3. pii: S0167-5273(21)00639.
    PubMed    
    Abstract available

  44. PFEUFFER-JOVIC E, Weiner S, Wilkens H, Schmitt D, et al
    Impact of the new definition of pulmonary hypertension according to world symposium of pulmonary hypertension 2018 on diagnosis of post-capillary pulmonary hypertension.
    Int J Cardiol. 2021 Apr 3. pii: S0167-5273(21)00642.
    PubMed    
    Abstract available

  45. REDDY SA, Nethercott SL, Khialani BV, Grace AA, et al
    Management of arrhythmias in pulmonary hypertension.
    J Interv Card Electrophysiol. 2021 Apr 5. pii: 10.1007/s10840-021-00988.
    PubMed    
    Abstract available

  46. LIN K, Sarnari R, Pathrose A, Gordon DZ, et al
    Cine MRI characterizes HFpEF and HFrEF in post-capillary pulmonary hypertension.
    Eur J Radiol. 2021;139:109679.
    PubMed    
    Abstract available

  47. ANDERSEN MO, Diederichsen SZ, Svendsen JH, Carlsen J, et al
    Assessment of cardiac arrhythmias using long-term continuous monitoring in patients with pulmonary hypertension.
    Int J Cardiol. 2021 Apr 2. pii: S0167-5273(21)00551.
    PubMed    
    Abstract available

  48. YANG X, Zhang L, Ye JQ, Wu XH, et al
    The role of ATG-7 contributes to pulmonary hypertension by impacting vascular remodeling.
    J Mol Cell Cardiol. 2021 Apr 2. pii: S0022-2828(21)00070.
    PubMed    
    Abstract available

  49. ALMEIDA-JONES M, Nawathe P, Markush D, Garg R, et al
    Atypical Causes of Severe Pulmonary Hypertension in Infancy.
    Glob Pediatr Health. 2021;8:2333794X211001240.
    PubMed    


  50. SONKAR SK, Alam M, Chandra S, Sonkar GK, et al
    Association of Pulmonary Hypertension With Inflammatory Markers and Volume Status in Hemodialysis Patients of End-Stage Renal Disease.
    Cureus. 2021;13:e13635.
    PubMed    
    Abstract available

  51. WERNHART S, Hedderich J, Weihe E
    Vital capacity and valvular dysfunction could serve as non-invasive predictors to screen for exercise pulmonary hypertension in the elderly based on a new diagnostic score.
    J Cardiovasc Thorac Res. 2021;13:68-78.
    PubMed    
    Abstract available

  52. SINDWANI G, Arora MK, Dhir A, Pamecha V, et al
    Unanticipated severe pulmonary hypertension in a patient undergoing living donor liver transplant - Role of milrinone and transesophageal echocardiography.
    Indian J Anaesth. 2021;65.
    PubMed    


  53. BARANSKA-PAWELCZAK K, Wojciechowska C, Jachec W
    DIAGNOSTIC AND PREDICTIVE VALUE OF RIGHT HEART CATHETERIZATION-DERIVED MEASUREMENTS IN PULMONARY HYPERTENSION.
    Wiad Lek. 2021;74.
    PubMed    
    Abstract available

  54. LEE SA, Hyun J, Yoon YI, Park SY, et al
    Clinical Impact of Mild to Moderate Pulmonary Hypertension in Living-Donor Liver Transplantation.
    Transpl Int. 2021 Apr 2. doi: 10.1111/tri.13875.
    PubMed    
    Abstract available

  55. TREMBLAY-GRAVEL M, Fortier A, Baron C, David C, et al
    Long-Chain Acylcarnitines and Monounsaturated Fatty Acids Discriminate Heart Failure Patients According to Pulmonary Hypertension Status.
    Metabolites. 2021;11.
    PubMed    
    Abstract available

  56. CHAKRAVARTY K, Antontsev VG, Khotimchenko M, Gupta N, et al
    Accelerated Repurposing and Drug Development of Pulmonary Hypertension Therapies for COVID-19 Treatment Using an AI-Integrated Biosimulation Platform.
    Molecules. 2021;26.
    PubMed    
    Abstract available

  57. TOMASZEWSKI M, Grywalska E, Topyla-Putowska W, Blaszczak P, et al
    High CD200 Expression on T CD4+ and T CD8+ Lymphocytes as a Non-Invasive Marker of Idiopathic Pulmonary Hypertension-Preliminary Study.
    J Clin Med. 2021;10.
    PubMed    
    Abstract available

  58. DAROCHA S, Araszkiewicz A, Kurzyna M, Banaszkiewicz M, et al
    Balloon Pulmonary Angioplasty in Technically Operable and Technically Inoperable Chronic Thromboembolic Pulmonary Hypertension.
    J Clin Med. 2021;10.
    PubMed    
    Abstract available

  59. GOUYOU B, Grun K, Kerschenmeyer A, Villa A, et al
    Therapeutic Evaluation of Antibody-Based Targeted Delivery of Interleukin 9 in Experimental Pulmonary Hypertension.
    Int J Mol Sci. 2021;22.
    PubMed    
    Abstract available

  60. ANJUM H, Surani S
    Pulmonary Hypertension in Pregnancy: A Review.
    Medicina (Kaunas). 2021;57.
    PubMed    
    Abstract available

  61. MURALIDHARAN P, Acosta MF, Gomez AI, Grijalva C, et al
    Design and Comprehensive Characterization of Tetramethylpyrazine (TMP) for Targeted Lung Delivery as Inhalation Aerosols in Pulmonary Hypertension (PH): In Vitro Human Lung Cell Culture and In Vivo Efficacy.
    Antioxidants (Basel). 2021;10.
    PubMed    
    Abstract available

  62. MUSTAFAOGLU R, Demir R, Aslan GK, Sinan UY, et al
    Does Duke Activity Status Index help predicting functional exercise capacity and long-term prognosis in patients with pulmonary hypertension?
    Respir Med. 2021;181:106375.
    PubMed    
    Abstract available

  63. KLOUDA T, Yuan K
    Inflammation in Pulmonary Arterial Hypertension.
    Adv Exp Med Biol. 2021;1303:351-372.
    PubMed    
    Abstract available

  64. LIANG S, Desai AA, Black SM, Tang H, et al
    Cytokines, Chemokines, and Inflammation in Pulmonary Arterial Hypertension.
    Adv Exp Med Biol. 2021;1303:275-303.
    PubMed    
    Abstract available

  65. NGO K
    Systemic Sclerosis and Pulmonary Disease.
    Adv Exp Med Biol. 2021;1303:173-182.
    PubMed    
    Abstract available

  66. HUANG A, Kandhi S, Sun D
    Roles of Genetic Predisposition in the Sex Bias of Pulmonary Pathophysiology, as a Function of Estrogens : Sex Matters in the Prevalence of Lung Diseases.
    Adv Exp Med Biol. 2021;1303:107-127.
    PubMed    
    Abstract available

  67. BARMAN SA, Bordan Z, Batori R, Haigh S, et al
    Galectin-3 Promotes ROS, Inflammation, and Vascular Fibrosis in Pulmonary Arterial Hypertension.
    Adv Exp Med Biol. 2021;1303:13-32.
    PubMed    
    Abstract available

  68. PAGALI S, Parikh RS
    Severe urticarial rash as the initial symptom of COVID-19 infection.
    BMJ Case Rep. 2021;14.
    PubMed    
    Abstract available

  69. LIU C, Chen J, Gao Y, Deng B, et al
    Endothelin receptor antagonists for pulmonary arterial hypertension.
    Cochrane Database Syst Rev. 2021;3:CD004434.
    PubMed    
    Abstract available

  70. BOENGLER K, Rohrbach S, Weissmann N, Schulz R, et al
    Importance of Cx43 for Right Ventricular Function.
    Int J Mol Sci. 2021;22.
    PubMed    
    Abstract available

  71. COMBS CA, Montgomery DM, Toner LE, Dildy GA, et al
    Society for Maternal-Fetal Medicine Special Statement: Checklist for initial management of amniotic fluid embolism.
    Am J Obstet Gynecol. 2021;224:B29-B32.
    PubMed    
    Abstract available

  72. YAN C, Pan X, Wan L, Li H, et al
    Combination of F-ASO and Targeted Medical Therapy in Patients With Secundum ASD and Severe PAH.
    JACC Cardiovasc Interv. 2020;13:2024-2034.
    PubMed    
    Abstract available

  73. WEATHERALD J, Dorfmuller P, Perros F, Ghigna MR, et al
    Pulmonary capillary haemangiomatosis: a distinct entity?
    Eur Respir Rev. 2020;29.
    PubMed    
    Abstract available

  74. BELLAN M, Dimagli A, Piccinino C, Giubertoni A, et al
    Role of Gas6 and TAM Receptors in the Identification of Cardiopulmonary Involvement in Systemic Sclerosis and Scleroderma Spectrum Disorders.
    Dis Markers. 2020;2020:2696173.
    PubMed    
    Abstract available

  75. SUGIMOTO K, Mochizuki Y, Kanda T, Ohnishi A, et al
    Atrial septal defect closure in a midget toy poodle.
    Open Vet J. 2020;10:11-15.
    PubMed    
    Abstract available

  76. LEWIS RA, Durrington C, Condliffe R, Kiely DG, et al
    BNP/NT-proBNP in pulmonary arterial hypertension: time for point-of-care testing?
    Eur Respir Rev. 2020;29.
    PubMed    
    Abstract available

  77. OAKES JM, Xu J, Morris TM, Fried ND, et al
    Effects of Chronic Nicotine Inhalation on Systemic and Pulmonary Blood Pressure and Right Ventricular Remodeling in Mice.
    Hypertension. 2020;75:1305-1314.
    PubMed    
    Abstract available

  78. TAKAGI K, Kawamoto M, Higuchi T, Tochimoto A, et al
    Single nucleotide polymorphisms of the HIF1A gene are associated with susceptibility to pulmonary arterial hypertension in systemic sclerosis and contribute to SSc-PAH disease severity.
    Int J Rheum Dis. 2020;23:674-680.
    PubMed    
    Abstract available

  79. JANUS M, Slawek-Szmyt S, Araszkiewicz A, Mularek-Kubzdela T, et al
    Atrial flow regulator as a bridge to lung transplant in a young patient with drug-resistant idiopathic pulmonary arterial hypertension.
    Kardiol Pol. 2020;78:461-462.
    PubMed    


  80. MORTIMER KM, Bartels DB, Hartmann N, Capapey J, et al
    Characterizing Health Outcomes in Idiopathic Pulmonary Fibrosis using US Health Claims Data.
    Respiration. 2020;99:108-118.
    PubMed    
    Abstract available

  81. ONALO R, Cooper P, Cilliers A, Nnebe-Agumadu U, et al
    Cardiovascular changes in children with sickle cell crisis.
    Cardiol Young. 2020;30:162-170.
    PubMed    
    Abstract available

  82. TALWAR S, George N, Gupta SK, Choudhary SK, et al
    Surgical repair for aortopulmonary window with interrupted aortic arch in late childhood.
    Cardiol Young. 2020;30:298-301.
    PubMed    
    Abstract available

  83. GOORSENBERG A, Kalverda KA, Annema J, Bonta P, et al
    Advances in Optical Coherence Tomography and Confocal Laser Endomicroscopy in Pulmonary Diseases.
    Respiration. 2020;99:190-205.
    PubMed    
    Abstract available

  84. FERGUSON DM, Gupta VS, Lally PA, Luco M, et al
    Early, Postnatal Pulmonary Hypertension Severity Predicts Inpatient Outcomes in Congenital Diaphragmatic Hernia.
    Neonatology. 2021 Apr 13:1-8. doi: 10.1159/000512966.
    PubMed    
    Abstract available

  85. KERR KM, Elliott CG, Benza RL, Channick RN, et al
    United States Chronic Thromboembolic Pulmonary Hypertension Registry: Protocol Design.
    JMIR Res Protoc. 2021 Apr 13. doi: 10.2196/25397.
    PubMed    
    Abstract available

  86. MARSHALL WH, Gee S, Lim W, Rajpal S, et al
    Correlation of echocardiographic probability of pulmonary hypertension with maternal outcomes in pregnant women with elevated right ventricular systolic pressure.
    Echocardiography. 2021 Apr 13. doi: 10.1111/echo.15050.
    PubMed    
    Abstract available

  87. GUARINO D, Saia F, Taglieri N, Dardi F, et al
    [Balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension:a paradigmatic case report].
    G Ital Cardiol (Rome). 2021;22:12-16.
    PubMed    
    Abstract available

  88. SAIA F, Dardi F, Taglieri N, Rotunno M, et al
    [Balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension: 5 years of experience in Italy].
    G Ital Cardiol (Rome). 2021;22:5-11.
    PubMed    
    Abstract available

  89. LIU HY, Lu TP, Tao CW, Wu YJ, et al
    Incidence of chronic thromboembolic pulmonary hypertension in Taiwan.
    J Formos Med Assoc. 2021 Apr 9. pii: S0929-6646(21)00127.
    PubMed    
    Abstract available

  90. VAN DE GROEP LD, van Thor MCJ, Mager JJ, Post MC, et al
    Evolution of patients with chronic thromboembolic pulmonary hypertension treated by balloon pulmonary angioplasty, according to their anticoagulant regimes.
    Heart Vessels. 2021 Apr 12. pii: 10.1007/s00380-021-01852.
    PubMed    


  91. LAREO A, Nuche J, Ropero MJC, Ynsaurriaga FA, et al
    Recent advances in pharmacotherapy of pulmonary hypertension: practical considerations.
    Kardiol Pol. 2021 Apr 5. doi: 10.33963/KP.15928.
    PubMed    


  92. AL-QADI M, LeVarge B, Ford HJ
    Epidemiology, Pathogenesis, and Clinical Approach in Group 5 Pulmonary Hypertension.
    Front Med (Lausanne). 2021;7:616720.
    PubMed    
    Abstract available

  93. HINKAMP CA, Shah T, Bartolome S, Torres F, et al
    Parenteral prostanoids for severe Group 3 pulmonary hypertension with right ventricular dysfunction.
    J Thorac Dis. 2021;13:1466-1475.
    PubMed    
    Abstract available

  94. ITO R, Yamashita J, Sasaki Y, Ikeda S, et al
    Efficacy and safety of balloon pulmonary angioplasty for residual pulmonary hypertension after pulmonary endarterectomy.
    Int J Cardiol. 2021 Apr 8. pii: S0167-5273(21)00649.
    PubMed    
    Abstract available

  95. DENG L, Liu X, Min J, Su Z, et al
    De Novo mutation of FOXF1 causes alveolar capillary dysplasia with misalignment of pulmonary veins: A case report.
    Medicine (Baltimore). 2021;100:e25375.
    PubMed    
    Abstract available

  96. PROHASKA CC, Machado RF
    Regional Variation in Methamphetamine-associated Pulmonary Arterial Hypertension: Who'd Better Call Saul?
    Ann Am Thorac Soc. 2021;18:584-585.
    PubMed    


  97. QIN Y, Qiao Y, Li L, Luo E, et al
    The m(6)A methyltransferase METTL3 promotes hypoxic pulmonary arterial hypertension.
    Life Sci. 2021;274:119366.
    PubMed    
    Abstract available

  98. BABICHEVA A, Makino A, Yuan JX
    mTOR Signaling in Pulmonary Vascular Disease: Pathogenic Role and Therapeutic Target.
    Int J Mol Sci. 2021;22.
    PubMed    
    Abstract available

  99. KAUR H, Sarma P, Bhattacharyya A, Prajapat M, et al
    Folic acid as placebo in controlled clinical trials of hydroxychloroquine prophylaxis in COVID-19: Is it scientifically justifiable?
    Med Hypotheses. 2021;149:110539.
    PubMed    
    Abstract available

  100. TAZ TA, Ahmed K, Paul BK, Al-Zahrani FA, et al
    Identification of biomarkers and pathways for the SARS-CoV-2 infections that make complexities in pulmonary arterial hypertension patients.
    Brief Bioinform. 2021;22:1451-1465.
    PubMed    
    Abstract available

  101. YAMAMURA A, Nayeem MJ, Sato M
    The Rho kinase 2 (ROCK2)-specific inhibitor KD025 ameliorates the development of pulmonary arterial hypertension.
    Biochem Biophys Res Commun. 2020 Nov 5. pii: S0006-291X(20)32035.
    PubMed    
    Abstract available

  102. HOPKINS SR, Sa RC, Prisk GK, Elliott AR, et al
    Abnormal pulmonary perfusion heterogeneity in patients with Fontan circulation and pulmonary arterial hypertension.
    J Physiol. 2021;599:343-356.
    PubMed    
    Abstract available

  103. LI C, Zhang Z, Xu Q, Shi R, et al
    Comprehensive Analyses of miRNA-mRNA Network and Potential Drugs in Idiopathic Pulmonary Arterial Hypertension.
    Biomed Res Int. 2020;2020:5156304.
    PubMed    
    Abstract available

  104. CIPRIANI A, Perazzolo Marra M, Bariani R, Mattesi G, et al
    Differential diagnosis of arrhythmogenic cardiomyopathy: phenocopies versus disease variants.
    Minerva Med. 2021;112:269-280.
    PubMed    
    Abstract available

  105. NAKAMURA D, Kondo R, Makiuchi A, Itagaki H, et al
    Extralobar sequestration with a pulmonary arterial feeding vessel.
    Gen Thorac Cardiovasc Surg. 2021;69:160-162.
    PubMed    
    Abstract available

  106. OWEN NE, Alexander GJ, Sen S, Bunclark K, et al
    Reduced circulating BMP10 and BMP9 and elevated endoglin are associated with disease severity, decompensation and pulmonary vascular syndromes in patients with cirrhosis.
    EBioMedicine. 2020;56:102794.
    PubMed    
    Abstract available

  107. ALSALEEM M, Hpa N, Kozielski R
    Case 3: Term Infant With Severe Respiratory Failure.
    Neoreviews. 2020;21:e349-e352.
    PubMed    


  108. HOLMES D, Corr M, Thomas G, Harbinson M, et al
    Protective effects of intermedin/adrenomedullin-2 in a cellular model of human pulmonary arterial hypertension.
    Peptides. 2020;126:170267.
    PubMed    
    Abstract available

  109. GUEVARA VELAZQUEZ V, Jodra Sanchez S, Hernandez-Mezquita MA, Lopez Zubizarreta M, et al
    An uncommon cause of dyspnea in a 64-year-old woman.
    Pulmonology. 2020;26:254-256.
    PubMed    


  110. KIRKPATRICK EC
    Pulmonary Hypertension as a Complication of Pediatric Cancer.
    Glob Pediatr Health. 2021;8:2333794X211009094.
    PubMed    
    Abstract available

  111. REDDY YNV
    Pulmonary Hypertension in Polycystic Ovarian Syndrome.
    Arq Bras Cardiol. 2021;116:812-813.
    PubMed    


  112. LUO L, Wu J, Lin T, Lian G, et al
    Influence of atorvastatin on metabolic pattern of rats with pulmonary hypertension.
    Aging (Albany NY). 2021;13.
    PubMed    
    Abstract available

  113. UKITA R, Tumen A, Stokes JW, Pinelli C, et al
    Progression Toward Decompensated Right Ventricular Failure in the Ovine Pulmonary Hypertension Model.
    ASAIO J. 2021 Apr 19. pii: 00002480-900000000-98286.
    PubMed    
    Abstract available

  114. QUAN R, Yang Y, Yang Z, Tian H, et al
    Risk prediction in medically treated chronic thromboembolic pulmonary hypertension.
    BMC Pulm Med. 2021;21:128.
    PubMed    
    Abstract available

  115. BANERJEE S, Puddu A
    Outcomes in Pulmonary Hypertension in Relation to Insurance Status: National Hospital Discharge Survey, 2000-2010.
    Turk Thorac J. 2021;22:182-183.
    PubMed    


  116. DUBROCK HM, Nathan SD, Reeve BB, Kolaitis NA, et al
    Pulmonary hypertension due to interstitial lung disease or chronic obstructive pulmonary disease: a patient experience study of symptoms and their impact on quality of life.
    Pulm Circ. 2021;11:20458940211005641.
    PubMed    
    Abstract available

  117. GILLMEYER KR, Miller DR, Glickman ME, Qian SX, et al
    Outcomes of pulmonary vasodilator use in Veterans with pulmonary hypertension associated with left heart disease and lung disease.
    Pulm Circ. 2021;11:20458940211001714.
    PubMed    
    Abstract available

  118. NATHAN SD, Barnett SD, King CS, Provencher S, et al
    Impact of the new definition for pulmonary hypertension in patients with lung disease: an analysis of the United Network for Organ Sharing database.
    Pulm Circ. 2021;11:2045894021999960.
    PubMed    
    Abstract available

  119. LI M, Riddle S, Kumar S, Poczobutt J, et al
    Microenvironmental Regulation of Macrophage Transcriptomic and Metabolomic Profiles in Pulmonary Hypertension.
    Front Immunol. 2021;12:640718.
    PubMed    
    Abstract available

  120. PARKER MW, Gottbrecht MF, Aurigemma GP
    Mid Systolic Notch and Pulmonary Hypertension: Pathophysiologic Mechanism and Technical Considerations.
    J Am Soc Echocardiogr. 2021 Apr 14. pii: S0894-7317(21)00188.
    PubMed    


  121. MIAO H, Chen Y, Wang C, Huang T, et al
    Pregnancies in women with moderate and severe pulmonary hypertension remain challenging: A single-center experience in East China.
    Int J Gynaecol Obstet. 2021 Apr 17. doi: 10.1002/ijgo.13708.
    PubMed    
    Abstract available

  122. LIU TX, Tanenbaum MT, Seo CH, Park D, et al
    Left Ventricular Diastolic Dysfunction and Pulmonary Hypertension: Outcomes in SAVR.
    Thorac Cardiovasc Surg. 2021 Apr 16. doi: 10.1055/s-0041-1727138.
    PubMed    
    Abstract available

  123. FANG X, Xie M, Liu X, He Y, et al
    CENPE contributes to pulmonary vascular remodeling in pulmonary hypertension.
    Biochem Biophys Res Commun. 2021;557:40-47.
    PubMed    
    Abstract available

  124. SHAH V, Shah RN, Greene L, DiMarino LM, et al
    Severe Pulmonary Hypertension in a Patient with Scurvy: Can a Vitamin Reverse It?
    Case Rep Med. 2021;2021:5519937.
    PubMed    
    Abstract available

  125. LENTINE KL, Lam NN, Caliskan Y, Xiao H, et al
    Incidence, Clinical Correlates, and Outcomes of Pulmonary Hypertension after Kidney Transplantation: Analysis of Linked U.S. Registry and Medicare Billing Claims.
    Transplantation. 2021 Apr 9. pii: 00007890-900000000-95275.
    PubMed    
    Abstract available

  126. CALDERON-COLMENERO J, Garcia-Montes JA, Aranda-Frausto A, Castillo-Castellon F, et al
    Common arterial trunk type I in a 15-year-old boy with grade I pulmonary hypertension.
    Rev Esp Cardiol (Engl Ed). 2021 Apr 12. pii: S1885-5857(21)00104.
    PubMed    


  127. IKEDA N, Amemiya K, Sato S, Iijima R, et al
    Evolution of patients with chronic thromboembolic pulmonary hypertension treated by balloon pulmonary angioplasty, according to their anticoagulant regimens : Letter to the editor (response to Liza D, et al.).
    Heart Vessels. 2021 Apr 15. pii: 10.1007/s00380-021-01854.
    PubMed    


  128. RUAN W, Yap J, Quah K, Cheah FK, et al
    Pulmonary endarterectomy and balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension: The Singapore experience.
    Ann Acad Med Singap. 2021;50:270-273.
    PubMed    


  129. KOPEC G, Dzikowska-Diduch O, Mroczek E, Mularek-Kubzdela T, et al
    Characteristics and outcomes of patients with chronic thromboembolic pulmonary hypertension in the era of modern therapeutic approaches: data from the Polish multicenter registry (BNP-PL).
    Ther Adv Chronic Dis. 2021;12:20406223211002961.
    PubMed    
    Abstract available

  130. MCGAHAN RK, Tang JE, Iyer MH, Flores AS, et al
    Combined Liver Kidney Transplant in Adult Patient With Alagille Syndrome and Pulmonary Hypertension.
    Semin Cardiothorac Vasc Anesth. 2021 Apr 14:10892532211008742.
    PubMed    
    Abstract available

  131. JOSE A, Zhou C, Baker R, Walker J, et al
    Predictive value of incidental right ventricular abnormalities identified on SPECT for mortality and pulmonary hypertension.
    J Nucl Cardiol. 2021 Apr 13. pii: 10.1007/s12350-021-02612.
    PubMed    
    Abstract available

  132. GROBS Y, Awada C, Lemay SE, Romanet C, et al
    Preclinical Investigation of Trifluoperazine as a Novel Therapeutic Agent for the Treatment of Pulmonary Arterial Hypertension.
    Int J Mol Sci. 2021;22.
    PubMed    
    Abstract available

  133. VAN UDEN D, Koudstaal T, van Hulst JAC, Bergen IM, et al
    Central Role of Dendritic Cells in Pulmonary Arterial Hypertension in Human and Mice.
    Int J Mol Sci. 2021;22.
    PubMed    
    Abstract available

  134. ZAFARI M, Rad MTS, Mohseni F, Nikbakht N, et al
    beta-Thalassemia Major and Coronavirus-19, Mortality and Morbidity: a Systematic Review Study.
    Hemoglobin. 2021;45:1-4.
    PubMed    
    Abstract available

  135. LINQING L, Yuhan Q, Erfei L, Yong Q, et al
    Hypoxia-induced PINK1/Parkin-mediated mitophagy promotes pulmonary vascular remodeling.
    Biochem Biophys Res Commun. 2021;534:568-575.
    PubMed    
    Abstract available

  136. IVY D, Frank BS
    Update on pediatric pulmonary arterial hypertension.
    Curr Opin Cardiol. 2021;36:67-79.
    PubMed    
    Abstract available

  137. PESTANA-FERNANDEZ M, Rubio-Rivas M, Tolosa-Vilella C, Guillen-Del-Castillo A, et al
    The incidence rate of pulmonary arterial hypertension and scleroderma renal crisis in systemic sclerosis patients with digital ulcers on endothelin antagonist receptors (ERAs) and phosphodiesterase-5 inhibitors (PDE5i).
    Rheumatology (Oxford). 2021;60:872-880.
    PubMed    
    Abstract available

  138. SAITO R, Kasajima A, Kawabata Y, Miki Y, et al
    Vasohibin-1 and miR-720 expression in diffuse pulmonary capillary hemangiomatosis-like changes associated with pulmonary hypoplasia.
    Pathol Int. 2020;70:470-472.
    PubMed    


  139. SEPULVEDA C, Repolho D, Antunes AM, Taulaigo AV, et al
    Dyspnea in antiphospholipid syndrome: Beyond pulmonary embolism.
    Rev Port Cardiol. 2020;39:47.
    PubMed    
    Abstract available

  140. MARTIN V, Sarker T, Slusarek E, McCarthy MA, et al
    Conversational avoidance during existential interviews with patients with progressive illness.
    Psychol Health Med. 2020;25:1073-1082.
    PubMed    
    Abstract available

  141. TANG P
    Clinical diagnostic value of circulating serum miR-509-3p in pulmonary arterial hypertension with congenital heart disease.
    Hellenic J Cardiol. 2020;61:26-30.
    PubMed    
    Abstract available

  142. BARKER CM, Cork DP, McCullough PA, Mehta HS, et al
    Comparison of Survival in Patients with Clinically Significant Tricuspid Regurgitation with and without Heart Failure (From the Optum Integrated File).
    Am J Cardiol. 2020 Dec 29. pii: S0002-9149(20)31422.
    PubMed    
    Abstract available

  143. STEMPEL JM, Gopalakrishnan A, Krishnamoorthy P, Lo KB, et al
    Pulmonary Arterial Hypertension in Hospitalized Patients with Polycythemia Vera (From the National Inpatient Database).
    Am J Cardiol. 2020 Dec 18. pii: S0002-9149(20)31350.
    PubMed    
    Abstract available

  144. FORBES LM, Gu S, Badesch DB
    Surrogate Markers for Pulmonary Hypertension May Inform Prognosis in Lung Cancer.
    Am J Respir Crit Care Med. 2021 Mar 31. doi: 10.1164/rccm.202103-0740.
    PubMed    


  145. AGARWAL S, de Jesus Perez VA
    In Defense of the Nucleus: NUDT1 and Oxidative DNA Damage in Pulmonary Arterial Hypertension.
    Am J Respir Crit Care Med. 2021;203:541-542.
    PubMed    


  146. VIELE K, Girard TD
    Risk, Results, and Costs: Optimizing Clinical Trial Efficiency through Prognostic Enrichment.
    Am J Respir Crit Care Med. 2021;203:671-672.
    PubMed    


  147. MORELL E, Gaies M, Fineman JR, Charpie J, et al
    Mortality from Pulmonary Hypertension in the Pediatric Cardiac Intensive Care Unit.
    Am J Respir Crit Care Med. 2021 Apr 2. doi: 10.1164/rccm.202011-4183.
    PubMed    
    Abstract available

  148. VITRY G, Paulin R, Grobs Y, Lampron MC, et al
    Oxidized DNA Precursors Cleanup by NUDT1 Contributes to Vascular Remodeling in Pulmonary Arterial Hypertension.
    Am J Respir Crit Care Med. 2021;203:614-627.
    PubMed    
    Abstract available

  149. HUMBERT M, Lau EMT
    Risk Stratification in Pulmonary Arterial Hypertension: Do Not Forget the Patient Perspective.
    Am J Respir Crit Care Med. 2021;203:675-677.
    PubMed    


  150. SCOTT JV, Garnett CE, Kanwar MK, Stockbridge NL, et al
    Enrichment Benefits of Risk Algorithms for Pulmonary Arterial Hypertension Clinical Trials.
    Am J Respir Crit Care Med. 2021;203:726-736.
    PubMed    
    Abstract available

  151. POCH D, Mandel J
    Pulmonary Hypertension.
    Ann Intern Med. 2021 Apr 13. doi: 10.7326/AITC202104200.
    PubMed    
    Abstract available

  152. HUANG J, Pan J, Wang Z, Wang D, et al
    BLTx Combined With Cardiac Correction in Treatment of PAH in Puerpera: Is It a Feasible Strategy?
    Ann Thorac Surg. 2021;111:e249-e251.
    PubMed    
    Abstract available

  153. HOWDEN EJ, Ruiz-Carmona S, Claeys M, de Bosscher R, et al
    Oxygen Pathway Limitations in Patients with Chronic Thromboembolic Pulmonary Hypertension.
    Circulation. 2021 Apr 15. doi: 10.1161/CIRCULATIONAHA.120.052899.
    PubMed    
    Abstract available

  154. OLDHAM WM, Hess E, Waldo SW, Humbert M, et al
    Integrating hemodynamics identifies an extreme pulmonary hypertension phenotype.
    Eur Respir J. 2021 Apr 8. pii: 13993003.04625-2020.
    PubMed    


  155. LLUCIA-VALLDEPERAS A, van Wezenbeek J, Goumans MJ, de Man FS, et al
    The battle of new biomarkers for right heart failure in pulmonary hypertension: is the queen of hearts NT-proBNP defeated at last?
    Eur Respir J. 2021;57.
    PubMed    


  156. BROBERG CS, Kovacs AH, Sadeghi S, Rosenbaum MS, et al
    COVID-19 in Adults With Congenital Heart Disease.
    J Am Coll Cardiol. 2021;77:1644-1655.
    PubMed    
    Abstract available

  157. WADIA RS, Bernier ML, Diaz-Rodriguez NM, Goswami DK, et al
    Update on Perioperative Pediatric Pulmonary Hypertension Management.
    J Cardiothorac Vasc Anesth. 2021 Feb 28. pii: S1053-0770(21)00190.
    PubMed    
    Abstract available

  158. HIRAIDE T, Kataoka M, Suzuki H, Aimi Y, et al
    Poor outcomes in carriers of the RNF213 variant (p.Arg4810Lys) with pulmonary arterial hypertension.
    J Heart Lung Transplant. 2020;39:103-112.
    PubMed    
    Abstract available

  159. GIRGIS RE, Hoeper MM
    Pulmonary hypertension in fibrosing idiopathic interstitial pneumonia: Uncertainties, challenges and opportunities.
    J Heart Lung Transplant. 2021 Mar 5. pii: S1053-2498(21)02221.
    PubMed    
    Abstract available

  160. ARTHUR ATAAM J, Mercier O, Lamrani L, Amsallem M, et al
    Retraction notice to ICAM-1 PROMOTES THE ABNORMAL ENDOTHELIAL CELL PHENOTYPE IN CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION.
    J Heart Lung Transplant. 2021;40:318.
    PubMed    
    Abstract available

  161. TOBITA K, Goda A, Nishida Y, Takeuchi K, et al
    Factors contributing to exercise capacity in chronic thromboembolic pulmonary hypertension with near-normal hemodynamics.
    J Heart Lung Transplant. 2021 Mar 5. pii: S1053-2498(21)02222.
    PubMed    
    Abstract available

  162. ROSENZWEIG EB, Ankola A, Krishnan U, Middlesworth W, et al
    A novel unidirectional-valved shunt approach for end-stage pulmonary arterial hypertension: Early experience in adolescents and adults.
    J Thorac Cardiovasc Surg. 2021;161:1438-1446.
    PubMed    
    Abstract available

  163. NEWMAN JH
    Molecular Rescue in Pulmonary Arterial Hypertension.
    N Engl J Med. 2021;384:1271-1272.
    PubMed    


  164. HUMBERT M, McLaughlin V, Gibbs JSR, Gomberg-Maitland M, et al
    Sotatercept for the Treatment of Pulmonary Arterial Hypertension.
    N Engl J Med. 2021;384:1204-1215.
    PubMed    
    Abstract available

  165. TAWA M, Nagata R, Sumi Y, Nakagawa K, et al
    Preventive effects of nitrate-rich beetroot juice supplementation on monocrotaline-induced pulmonary hypertension in rats.
    PLoS One. 2021;16:e0249816.
    PubMed    
    Abstract available

  166. DANEVA Z, Marziano C, Ottolini M, Chen YL, et al
    Caveolar peroxynitrite formation impairs endothelial TRPV4 channels and elevates pulmonary arterial pressure in pulmonary hypertension.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed    
    Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Pulmonary Hypertension is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design:


;